STT-5058 / Staten Biotech 
Welcome,         Profile    Billing    Logout  
 0 Diseases   0 Trials   0 Trials   0 News 
  • ||||||||||  STT-5058 / Staten Biotech
    Enrollment closed:  A First in Human Study of STT-5058, an Antibody That Binds ApoC3 (clinicaltrials.gov) -  Oct 6, 2022   
    P1,  N=93, Active, not recruiting, 
    Active, not recruiting --> Terminated; recruitment failure Recruiting --> Active, not recruiting
  • ||||||||||  STT-5058 / Staten Biotech
    Trial completion date, Trial primary completion date:  A First in Human Study of STT-5058, an Antibody That Binds ApoC3 (clinicaltrials.gov) -  Jun 21, 2022   
    P1,  N=104, Recruiting, 
    Recruiting --> Active, not recruiting Trial completion date: Jul 2022 --> Oct 2022 | Trial primary completion date: Jul 2022 --> Oct 2022
  • ||||||||||  STT-5058 / Staten Biotech
    Trial completion date, Trial primary completion date:  A First in Human Study of STT-5058, an Antibody That Binds ApoC3 (clinicaltrials.gov) -  Nov 10, 2021   
    P1,  N=104, Recruiting, 
    Trial completion date: Jul 2022 --> Oct 2022 | Trial primary completion date: Jul 2022 --> Oct 2022 Trial completion date: Oct 2021 --> Jul 2022 | Trial primary completion date: Oct 2021 --> Jul 2022
  • ||||||||||  STT-5058 / Staten Biotech
    Trial completion date, Trial primary completion date:  A First in Human Study of STT-5058, an Antibody That Binds ApoC3 (clinicaltrials.gov) -  Aug 18, 2021   
    P1,  N=104, Recruiting, 
    Trial completion date: Oct 2021 --> Jul 2022 | Trial primary completion date: Oct 2021 --> Jul 2022 Trial completion date: May 2021 --> Oct 2021 | Trial primary completion date: May 2021 --> Oct 2021
  • ||||||||||  STT-5058 / Staten Biotech
    Enrollment open:  A First in Human Study of STT-5058, an Antibody That Binds ApoC3 (clinicaltrials.gov) -  Jun 11, 2020   
    P1,  N=104, Recruiting, 
    Trial completion date: May 2021 --> Oct 2021 | Trial primary completion date: May 2021 --> Oct 2021 Not yet recruiting --> Recruiting